₹0.00
In light of the ongoing coronavirus outbreak, the government has imposed restrictions on the export of 26 pharmaceutical ingredients. Active Pharmaceutical Ingredients: Active Pharmaceutical Ingredient or API is the raw material used for drug manufacture. It is the actual component that brings about the intended effect. Some drugs have multiple APIs. A drug is composed ..
India and the African Union have signed a MoU to establish a collaborative platform for Healthcare sector. This agreement will make the way for cooperation in research and development, capacity building, health services, pharmaceutical trade and manufacturing capabilities for diagnostics and drugs. In order to build up the scenario of a structured partnership in the ..
Recently, National drug pricing regulator NPPA has fixed the retail prices of 36 formulations, including those used for treatment of cancer, diabetes, infections, asthma, seizures, inflammation and pain, among others. As per data available with NPPA, the MRP for 105 brands will be reduced up to 85% entailing minimum saving of Rs 105 crore to ..
Kerala has become the first State to set up a Price Monitoring and Research Unit (PMRU) to track violation of prices of essential drugs and medical devices under the Drugs Price Control Order (DPCO). The move comes more than 5 years after the National Pharmaceutical Pricing Authority (NPPA) proposed such a system for the States ..
In a landmark ruling, the Delhi High Court has ordered a ban on the sale of medicines online by e-pharmacists across India and has directed the Delhi government and the Centre to put the order into effect immediately. The order was passed by a division bench of Chief Justice Rajendra Menon and Justice V Kameswar ..
In its 2018 edition of Indian Pharmacopoeia, the Indian Pharmacopoeia Commission (IPC) has approved modern, animal-free tests for drug manufacturers. This step would spare animals from suffering due to drug experiments. The 2018 edition of Indian Pharmacopoeia has provided guidelines on tests for drugs manufactured and marketed in India. In it, IPC has replaced the ..
The Draft Pharmaceutical Policy 2017 has been introduced by the Department of Pharmaceuticals with the objective of regulating the production and marketing of pharmaceutical products in India. Salient Features Key features of this policy are as follows: Price Control to Monitoring The new policy has an aim of reorienting the Drug Price Control Order (DPCO) ..
Delhi High Court has given a major relief to the pharmaceutical sector by lifting a ban on more than 300 fixed dose combination drugs. 344 drugs had been banned due to potential health risks and an apparent lack of therapeutic justification. Fixed Dose Combination Drugs is a mixture of more than two drugs in a ..